Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
about
Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issuesEvaluation of preferences of women and healthcare professionals in Singapore for implementation of noninvasive prenatal testing for Down syndrome.An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population.Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.Advantages of the Quadruple Screen over noninvasive prenatal testing.Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.Overview of the impact of noninvasive prenatal testing on diagnostic procedures.QUAD versus cfDNA in an urban population in the second trimester for detection of trisomy 21: a cost sensitivity analysis.Contingent non-invasive prenatal testing: an opportunity to improve non-genetic aspects of fetal aneuploidy screening.Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review.Is maternal plasma DNA testing impacting serum-based screening for aneuploidy in the United States?Challenges in non-invasive prenatal screening for sub-chromosomal copy number variations using cell-free DNA.Diagnostic performance and costs of contingent screening models for trisomy 21 incorporating non-invasive prenatal testing.Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis.Detection of a case of chronic myeloid leukaemia with deletions at the t(9;22) translocation breakpoints by a genome-wide non-invasive prenatal test.New technologies to reduce medicalization of prenatal care: a contradiction with realistic perspectives.
P2860
Q26764809-920568A0-BD31-4228-B05C-7C203E13BA9DQ33809800-8DD7A8AD-2DA4-42DE-AAB9-F554FAB2BD0FQ35686965-7FCCA6B7-EC2F-493F-847E-075A401F2396Q36184534-3AC6C92A-C2C1-4AB2-BFB9-AC8C6A149C35Q36632770-DF27C6DD-C9EA-40C3-8065-736D2B871854Q37067727-E242D9F1-4B1E-404F-BA20-6C9D0BB3DF45Q38418823-FD75E37B-2527-4212-9FD5-9B16DA40708EQ40413919-4C79CDA5-FC20-4899-B3CE-A5346E6D696BQ40459322-B0657605-AE9B-4E10-A540-D160054FE4C1Q47296123-A3A2322C-3362-4A33-ABDB-64BE1C9BCCCDQ48207275-54C175D6-3A89-4595-B736-AD5E9AEC3B40Q48285694-E090421D-0CBE-4F13-854F-98350803AF11Q48335557-BAA0971C-5169-422B-A069-4459EFEFF2E2Q48374688-E795737B-63F8-4104-B827-701D5ED474A7Q51706611-81F31261-AE3D-495B-8D49-CC7758C20B99Q54483132-734401FA-CEDB-4C5E-9D2B-105D2736A5A3
P2860
Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Introducing the non-invasive p ...... : a cost-consequences analysis
@ast
Introducing the non-invasive p ...... : a cost-consequences analysis
@en
Introducing the non-invasive p ...... : a cost-consequences analysis
@nl
type
label
Introducing the non-invasive p ...... : a cost-consequences analysis
@ast
Introducing the non-invasive p ...... : a cost-consequences analysis
@en
Introducing the non-invasive p ...... : a cost-consequences analysis
@nl
prefLabel
Introducing the non-invasive p ...... : a cost-consequences analysis
@ast
Introducing the non-invasive p ...... : a cost-consequences analysis
@en
Introducing the non-invasive p ...... : a cost-consequences analysis
@nl
P2093
P2860
P1433
P1476
Introducing the non-invasive p ...... : a cost-consequences analysis
@en
P2093
Frank Hulstaert
Mattias Neyt
Wilfried Gyselaers
P2860
P304
P356
10.1136/BMJOPEN-2014-005922
P577
2014-11-07T00:00:00Z